Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies

Lignende værker

• Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
  af: Montastruc, Jean-Louis, et al.
  Udgivet: (2011)
• Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol)
  af: Tavassoli, Neda, et al.
  Udgivet: (2009)
• Adverse drug reactions and off-label drug use in paediatric outpatients
  af: Horen, Benjamin, et al.
  Udgivet: (2002)
• Trends of reporting of ‘serious’vs. ‘non-serious’ adverse drug reactions over time: a study in the French PharmacoVigilance Database
  af: Moulis, Guillaume, et al.
  Udgivet: (2012)
• Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
  af: Jouanjus, Emilie, et al.
  Udgivet: (2019)